Placental expression of VEGF family mRNA in adverse pregnancy outcomes

The pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21% of all pregnancies. The Vascular Endothelial Growth Factor family (VEGF) is implicated in the pathogenesis of these complications. We aimed to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Placenta (Eastbourne) Jg. 33; H. 6; S. 467 - 472
Hauptverfasser: Andraweera, P.H., Dekker, G.A., Laurence, J.A., Roberts, C.T.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Kidlington Elsevier Ltd 01.06.2012
Elsevier
Schlagworte:
ISSN:0143-4004, 1532-3102, 1532-3102
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21% of all pregnancies. The Vascular Endothelial Growth Factor family (VEGF) is implicated in the pathogenesis of these complications. We aimed to evaluate the placental mRNA expression of VEGFA, PGF, FLT1 and KDR in pregnancies complicated by preeclampsia, gestational hypertension, SGA infants and pre-term birth. Placentae were collected at delivery from women with pregnancies complicated by preeclampsia (n = 18), gestational hypertension (n = 15), normotensive SGA infants (n = 13), late spontaneous pre-term birth (n = 10) and uncomplicated pregnancy (n = 30). RNA was extracted and VEGFA, PGF, FLT1 and KDR expression were quantified using qRT-PCR. Kruskal Wallis test was used to compare placental mRNA expression in the adverse pregnancy outcome groups compared to uncomplicated term pregnancy. Compared to placental mRNA from uncomplicated pregnancies, VEGFA (p = 0.006), PGF (p < 0.001), KDR (p < 0.001) and FLT1 (p = 0.02) mRNA were reduced in preeclamptic placentae; VEGFA (p < 0.001), PGF (p = 0.01) and KDR (p = 0.008) mRNA were reduced in placentae from pregnancies complicated by gestational hypertension; VEGFA (p = 0.03) mRNA was reduced in normotensive SGA pregnancies; VEGFA (p = 0.008), PGF (p = 0.01), KDR (p = 0.04) and FLT1 (p = 0.02) mRNA were reduced in placentae from late PTB. VEGF family of angiogenic growth factor mRNA expression in the placenta is reduced in gestational hypertensive disorders, SGA and in pre-term birth.
AbstractList The pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21% of all pregnancies. The Vascular Endothelial Growth Factor family (VEGF) is implicated in the pathogenesis of these complications. We aimed to evaluate the placental mRNA expression of VEGFA, PGF, FLT1 and KDR in pregnancies complicated by preeclampsia, gestational hypertension, SGA infants and pre-term birth.INTRODUCTIONThe pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21% of all pregnancies. The Vascular Endothelial Growth Factor family (VEGF) is implicated in the pathogenesis of these complications. We aimed to evaluate the placental mRNA expression of VEGFA, PGF, FLT1 and KDR in pregnancies complicated by preeclampsia, gestational hypertension, SGA infants and pre-term birth.Placentae were collected at delivery from women with pregnancies complicated by preeclampsia (n = 18), gestational hypertension (n = 15), normotensive SGA infants (n = 13), late spontaneous pre-term birth (n = 10) and uncomplicated pregnancy (n = 30). RNA was extracted and VEGFA, PGF, FLT1 and KDR expression were quantified using qRT-PCR. Kruskal Wallis test was used to compare placental mRNA expression in the adverse pregnancy outcome groups compared to uncomplicated term pregnancy.METHODPlacentae were collected at delivery from women with pregnancies complicated by preeclampsia (n = 18), gestational hypertension (n = 15), normotensive SGA infants (n = 13), late spontaneous pre-term birth (n = 10) and uncomplicated pregnancy (n = 30). RNA was extracted and VEGFA, PGF, FLT1 and KDR expression were quantified using qRT-PCR. Kruskal Wallis test was used to compare placental mRNA expression in the adverse pregnancy outcome groups compared to uncomplicated term pregnancy.Compared to placental mRNA from uncomplicated pregnancies, VEGFA (p = 0.006), PGF (p < 0.001), KDR (p < 0.001) and FLT1 (p = 0.02) mRNA were reduced in preeclamptic placentae; VEGFA (p < 0.001), PGF (p = 0.01) and KDR (p = 0.008) mRNA were reduced in placentae from pregnancies complicated by gestational hypertension; VEGFA (p = 0.03) mRNA was reduced in normotensive SGA pregnancies; VEGFA (p = 0.008), PGF (p = 0.01), KDR (p = 0.04) and FLT1 (p = 0.02) mRNA were reduced in placentae from late PTB.RESULTSCompared to placental mRNA from uncomplicated pregnancies, VEGFA (p = 0.006), PGF (p < 0.001), KDR (p < 0.001) and FLT1 (p = 0.02) mRNA were reduced in preeclamptic placentae; VEGFA (p < 0.001), PGF (p = 0.01) and KDR (p = 0.008) mRNA were reduced in placentae from pregnancies complicated by gestational hypertension; VEGFA (p = 0.03) mRNA was reduced in normotensive SGA pregnancies; VEGFA (p = 0.008), PGF (p = 0.01), KDR (p = 0.04) and FLT1 (p = 0.02) mRNA were reduced in placentae from late PTB.VEGF family of angiogenic growth factor mRNA expression in the placenta is reduced in gestational hypertensive disorders, SGA and in pre-term birth.CONCLUSIONVEGF family of angiogenic growth factor mRNA expression in the placenta is reduced in gestational hypertensive disorders, SGA and in pre-term birth.
The pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21% of all pregnancies. The Vascular Endothelial Growth Factor family (VEGF) is implicated in the pathogenesis of these complications. We aimed to evaluate the placental mRNA expression of VEGFA, PGF, FLT1 and KDR in pregnancies complicated by preeclampsia, gestational hypertension, SGA infants and pre-term birth. Placentae were collected at delivery from women with pregnancies complicated by preeclampsia (n = 18), gestational hypertension (n = 15), normotensive SGA infants (n = 13), late spontaneous pre-term birth (n = 10) and uncomplicated pregnancy (n = 30). RNA was extracted and VEGFA, PGF, FLT1 and KDR expression were quantified using qRT-PCR. Kruskal Wallis test was used to compare placental mRNA expression in the adverse pregnancy outcome groups compared to uncomplicated term pregnancy. Compared to placental mRNA from uncomplicated pregnancies, VEGFA (p = 0.006), PGF (p < 0.001), KDR (p < 0.001) and FLT1 (p = 0.02) mRNA were reduced in preeclamptic placentae; VEGFA (p < 0.001), PGF (p = 0.01) and KDR (p = 0.008) mRNA were reduced in placentae from pregnancies complicated by gestational hypertension; VEGFA (p = 0.03) mRNA was reduced in normotensive SGA pregnancies; VEGFA (p = 0.008), PGF (p = 0.01), KDR (p = 0.04) and FLT1 (p = 0.02) mRNA were reduced in placentae from late PTB. VEGF family of angiogenic growth factor mRNA expression in the placenta is reduced in gestational hypertensive disorders, SGA and in pre-term birth.
AbstractIntroductionThe pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21% of all pregnancies. The Vascular Endothelial Growth Factor family (VEGF) is implicated in the pathogenesis of these complications. We aimed to evaluate the placental mRNA expression of VEGFA, PGF, FLT1 and KDR in pregnancies complicated by preeclampsia, gestational hypertension, SGA infants and pre-term birth. MethodPlacentae were collected at delivery from women with pregnancies complicated by preeclampsia ( n = 18), gestational hypertension ( n = 15), normotensive SGA infants ( n = 13), late spontaneous pre-term birth ( n = 10) and uncomplicated pregnancy ( n = 30). RNA was extracted and VEGFA, PGF, FLT1 and KDR expression were quantified using qRT-PCR. Kruskal Wallis test was used to compare placental mRNA expression in the adverse pregnancy outcome groups compared to uncomplicated term pregnancy. ResultsCompared to placental mRNA from uncomplicated pregnancies, VEGFA ( p = 0.006) , PGF ( p < 0.001) , KDR ( p < 0.001) and FLT1 ( p = 0.02) mRNA were reduced in preeclamptic placentae; VEGFA ( p < 0.001), PGF ( p = 0.01) and KDR ( p = 0.008) mRNA were reduced in placentae from pregnancies complicated by gestational hypertension; VEGFA ( p = 0.03) mRNA was reduced in normotensive SGA pregnancies; VEGFA ( p = 0.008), PGF ( p = 0.01), KDR ( p = 0.04) and FLT1 ( p = 0.02) mRNA were reduced in placentae from late PTB. ConclusionVEGF family of angiogenic growth factor mRNA expression in the placenta is reduced in gestational hypertensive disorders, SGA and in pre-term birth.
The pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21% of all pregnancies. The Vascular Endothelial Growth Factor family (VEGF) is implicated in the pathogenesis of these complications. We aimed to evaluate the placental mRNA expression of VEGFA, PGF, FLT1 and KDR in pregnancies complicated by preeclampsia, gestational hypertension, SGA infants and pre-term birth. Placentae were collected at delivery from women with pregnancies complicated by preeclampsia (n = 18), gestational hypertension (n = 15), normotensive SGA infants (n = 13), late spontaneous pre-term birth (n = 10) and uncomplicated pregnancy (n = 30). RNA was extracted and VEGFA, PGF, FLT1 and KDR expression were quantified using qRT-PCR. Kruskal Wallis test was used to compare placental mRNA expression in the adverse pregnancy outcome groups compared to uncomplicated term pregnancy. Compared to placental mRNA from uncomplicated pregnancies, VEGFA (p = 0.006), PGF (p < 0.001), KDR (p < 0.001) and FLT1 (p = 0.02) mRNA were reduced in preeclamptic placentae; VEGFA (p < 0.001), PGF (p = 0.01) and KDR (p = 0.008) mRNA were reduced in placentae from pregnancies complicated by gestational hypertension; VEGFA (p = 0.03) mRNA was reduced in normotensive SGA pregnancies; VEGFA (p = 0.008), PGF (p = 0.01), KDR (p = 0.04) and FLT1 (p = 0.02) mRNA were reduced in placentae from late PTB. VEGF family of angiogenic growth factor mRNA expression in the placenta is reduced in gestational hypertensive disorders, SGA and in pre-term birth.
Author Roberts, C.T.
Laurence, J.A.
Dekker, G.A.
Andraweera, P.H.
Author_xml – sequence: 1
  givenname: P.H.
  surname: Andraweera
  fullname: Andraweera, P.H.
  organization: Discipline of Obstetrics and Gynaecology, Research Centre for Reproductive Health, University of Adelaide, Adelaide, Australia
– sequence: 2
  givenname: G.A.
  surname: Dekker
  fullname: Dekker, G.A.
  organization: Discipline of Obstetrics and Gynaecology, Research Centre for Reproductive Health, University of Adelaide, Adelaide, Australia
– sequence: 3
  givenname: J.A.
  surname: Laurence
  fullname: Laurence, J.A.
  organization: Discipline of Obstetrics and Gynaecology, Research Centre for Reproductive Health, University of Adelaide, Adelaide, Australia
– sequence: 4
  givenname: C.T.
  surname: Roberts
  fullname: Roberts, C.T.
  email: claire.roberts@adelaide.edu.au
  organization: Discipline of Obstetrics and Gynaecology, Research Centre for Reproductive Health, University of Adelaide, Adelaide, Australia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25876974$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22386962$$D View this record in MEDLINE/PubMed
BookMark eNqNkl1rFDEUhoNU7Lb6F8rcCN7M9uRjMjsgYindWigqft2GJHMiWWeSNZkt7r83y24VemGFA-fmed_kvOeckKMQAxJyRmFOgcrz1Xw9aIth0nMGlM2hFOVPyIw2nNWcAjsiM6CC1wJAHJOTnFcA0AnKnpFjxvhCdpLNyPLjwWao8Nc6Yc4-hiq66tvV9bJyevTDtho_vb-ofKh0f4cpY1W470EHu63iZrJxxPycPHV6yPji0E_J1-XVl8t39e2H65vLi9vaNq2Yamyco6Jz2nS6bwxvm8ZKi7pvwfTWGI6ybaRxQqBBhn3XOyas0B1IMKbt-Cl5tfddp_hzg3lSo88Wh0EHjJusSjYlgAVvaUHPDujGjNirdfKjTlt1P3sBXh4Ana0eXCoT-fyXaxat7FpROLnnbIo5J3R_EAq7B6VaqftlqN0yFJSivAhfPxBaP-mpBDwl7YfH5W_3ciyB3nlMKluPwWLvE9pJ9dE_bvHmgYUdfPBl2h-4xbyKmxTKuhRVuQjU593B7O6FMgAKwP5t8D8_-A0VBtOB
CODEN PLACDF
CitedBy_id crossref_primary_10_1007_s00418_021_02069_7
crossref_primary_10_3390_ijms21041305
crossref_primary_10_1161_HYPERTENSIONAHA_123_22353
crossref_primary_10_1177_1099800418760997
crossref_primary_10_1530_REP_16_0014
crossref_primary_10_4103_CJP_CJP_15_19
crossref_primary_10_1186_s12884_019_2450_0
crossref_primary_10_1016_j_bbrc_2020_02_137
crossref_primary_10_1007_s00418_025_02359_4
crossref_primary_10_1016_j_jri_2022_103490
crossref_primary_10_1155_2016_7124186
crossref_primary_10_1586_eem_12_79
crossref_primary_10_1016_j_placenta_2023_07_002
crossref_primary_10_1016_j_bbadis_2018_06_013
crossref_primary_10_1080_15257770_2023_2283621
crossref_primary_10_1186_1868_7083_5_6
crossref_primary_10_3389_fmolb_2021_709751
crossref_primary_10_1038_srep04459
crossref_primary_10_1016_j_placenta_2013_01_011
crossref_primary_10_1016_j_placenta_2024_09_002
crossref_primary_10_1155_2017_3179670
crossref_primary_10_1155_2022_8314838
crossref_primary_10_2217_epi_2020_0318
crossref_primary_10_1016_j_placenta_2017_04_025
crossref_primary_10_1038_s41598_017_12685_w
crossref_primary_10_1038_s41598_017_17614_5
crossref_primary_10_1016_j_placenta_2014_04_008
crossref_primary_10_1097_FPC_0000000000000125
crossref_primary_10_1016_j_critrevonc_2020_103192
crossref_primary_10_1016_j_jhazmat_2015_02_005
crossref_primary_10_1007_s12253_014_9872_9
crossref_primary_10_3389_fphar_2014_00134
crossref_primary_10_1155_2022_7832618
crossref_primary_10_1007_s11302_012_9341_4
crossref_primary_10_1093_humrep_det339
crossref_primary_10_3390_vetsci9060302
crossref_primary_10_1007_s10815_022_02677_9
crossref_primary_10_1038_s41433_024_02992_8
crossref_primary_10_3389_fphys_2019_00562
crossref_primary_10_1007_s13224_018_1128_2
crossref_primary_10_1159_000357704
crossref_primary_10_1038_srep15221
crossref_primary_10_1016_j_placenta_2022_03_127
crossref_primary_10_1177_1933719114532838
crossref_primary_10_1002_pd_4974
crossref_primary_10_1155_2018_1639623
crossref_primary_10_29252_ijrm_15_3_169
crossref_primary_10_1007_s43032_019_00103_7
crossref_primary_10_1080_10641955_2017_1291673
crossref_primary_10_1161_HYPERTENSIONAHA_117_10510
crossref_primary_10_31083_j_ceog4909211
crossref_primary_10_1007_s11010_017_3121_y
crossref_primary_10_1007_s13353_023_00823_2
crossref_primary_10_1080_17501911_2024_2438593
crossref_primary_10_3389_fphys_2018_01591
crossref_primary_10_3390_ijms22010285
crossref_primary_10_1111_jog_13592
crossref_primary_10_1189_jlb_3HI0515_200RR
crossref_primary_10_1016_j_ajog_2015_11_002
crossref_primary_10_1002_bdrc_21031
crossref_primary_10_3892_etm_2019_7184
crossref_primary_10_1016_j_prp_2014_11_003
crossref_primary_10_1007_s11906_019_0970_7
crossref_primary_10_1016_j_placenta_2014_01_007
Cites_doi 10.1016/S0143-4004(97)80061-6
10.1038/nm1452
10.1038/376066a0
10.1530/jrf.0.0990609
10.1067/S0002-9378(03)00838-X
10.1016/j.placenta.2003.10.010
10.1186/1471-2105-6-62
10.1038/376062a0
10.1111/j.1538-7836.2011.04494.x
10.1189/jlb.0406250
10.1677/joe.0.1590459
10.1071/RD06131
10.1095/biolreprod56.2.489
10.1038/nm0603-669
10.1111/j.1471-0528.2004.00143.x
10.1111/j.1365-3016.2008.00971.x
10.1111/j.1471-0528.1986.tb07830.x
10.1001/archpediatrics.2011.796
10.1093/oxfordjournals.humrep.a019303
10.1111/j.1479-828X.2004.00272.x
10.3109/08977199509036883
10.1177/1933719111428520
10.1016/j.placenta.2005.05.011
10.1016/j.bpobgyn.2011.01.006
10.1016/j.placenta.2003.10.004
10.1034/j.1600-0412.2001.080002093.x
10.1038/87904
10.1067/mob.2002.127720
10.1111/j.1471-0528.1996.tb09627.x
10.1016/j.placenta.2010.12.008
10.1056/NEJMoa031884
10.1136/bmj.b1081
10.1016/S0006-2952(02)01168-1
10.1016/0143-4004(94)90002-7
10.1210/jc.2003-031580
10.1016/j.placenta.2003.11.011
10.1038/380435a0
10.3109/08977199609003225
10.1038/380439a0
10.1080/09513590701350291
10.1016/j.placenta.2010.11.018
ContentType Journal Article
Copyright 2012 Elsevier Ltd
Elsevier Ltd
2015 INIST-CNRS
Copyright © 2012 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2012 Elsevier Ltd
– notice: Elsevier Ltd
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.placenta.2012.02.013
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Zoology
EISSN 1532-3102
EndPage 472
ExternalDocumentID 22386962
25876974
10_1016_j_placenta_2012_02_013
S0143400412001002
1_s2_0_S0143400412001002
Genre Multicenter Study
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABGSF
ABJNI
ABMAC
ABMZM
ABOCM
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
ADVLN
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEC
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LG5
LUGTX
M28
M2X
M41
MO0
N9A
O-L
O9-
OAUVE
OQ.
OZT
P-8
P-9
P2P
PC.
PH~
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSI
SSU
SSZ
T5K
WUQ
Z5R
ZGI
~G-
~HD
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
DOVZS
LCYCR
9DU
AAYXX
CITATION
AGCQF
AGRNS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c574t-e5ff149fab9ad5b3755c6cead70bdcbb3e6756bf44ebe2ed9df24c4a9060bb793
ISICitedReferencesCount 78
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000304518200003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0143-4004
1532-3102
IngestDate Sun Sep 28 11:02:41 EDT 2025
Mon Jul 21 05:35:29 EDT 2025
Mon Jul 21 09:16:18 EDT 2025
Tue Nov 18 21:17:18 EST 2025
Sat Nov 29 07:23:49 EST 2025
Fri Feb 23 02:31:13 EST 2024
Sun Feb 23 10:18:50 EST 2025
Tue Oct 14 19:31:18 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Pre-term birth
VEGF family
mRNA
Placenta
SGA
Preeclampsia
Pregnancy
Vertebrata
Vascular endothelium growth factor
Mammalia
Prognosis
Fetal membrane
Gene expression
Language English
License CC BY 4.0
Copyright © 2012 Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c574t-e5ff149fab9ad5b3755c6cead70bdcbb3e6756bf44ebe2ed9df24c4a9060bb793
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22386962
PQID 1011538371
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1011538371
pubmed_primary_22386962
pascalfrancis_primary_25876974
crossref_primary_10_1016_j_placenta_2012_02_013
crossref_citationtrail_10_1016_j_placenta_2012_02_013
elsevier_sciencedirect_doi_10_1016_j_placenta_2012_02_013
elsevier_clinicalkeyesjournals_1_s2_0_S0143400412001002
elsevier_clinicalkey_doi_10_1016_j_placenta_2012_02_013
PublicationCentury 2000
PublicationDate 2012-06-01
PublicationDateYYYYMMDD 2012-06-01
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: Netherlands
PublicationTitle Placenta (Eastbourne)
PublicationTitleAlternate Placenta
PublicationYear 2012
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Demir, Kayisli, Seval, Celik-Ozenci, Korgun, Demir-Weusten (bib34) 2004; 25
Sharkey, Charnock-Jones, Boocock, Brown, Smith (bib16) 1993; 99
Bodnar, Simhan (bib2) 2008; 22
Ferrara, Carver-Moore, Chen, Dowd, Lu, O'Shea (bib10) 1996; 380
Carmeliet, Moons, Luttun, Vincenti, Compernolle, De Mol (bib9) 2001; 7
McCowan, Dekker, Chan, Stewart, Chappell, Hunter (bib24) 2009; 338
Larionov, Krause, Miller (bib28) 2005; 6
Cooper, Sharkey, Charnock-Jones, Palmer, Smith (bib19) 1996; 103
Ahmed, Li, Dunk, Whittle, Rushton, Rollason (bib31) 1995; 12
Mayhew, Charnock-Jones, Kaufmann (bib4) 2004; 25
Clark, Smith, Licence, Evans, Charnock-Jones (bib30) 1998; 159
Chung, Song, Wang, Magness, Zheng (bib21) 2004; 89
Sgambati, Marini, Zappoli Thyrion, Parretti, Mello, Orlando (bib23) 2004; 111
Nelson, Burton (bib29) 2011; 32
Khong, De Wolf, Robertson, Brosens (bib3) 1986; 93
Kim, Chaiworapongsa, Gomez, Bujold, Yoon, Rotmensch (bib6) 2002; 187
Demir, Kayisli, Cayli, Huppertz (bib33) 2006; 27
Schiessl, Innes, Bulmer, Otun, Chadwick, Robson (bib15) 2008
Marini, Vichi, Toscano, Zappoli Thyrion, Parretti, Mello (bib40) 2007; 19
Kim, Bujold, Chaiworapongsa, Gomez, Yoon, Thaler (bib5) 2003; 189
Carmeliet, Ferreira, Breier, Pollefeyt, Kieckens, Gertsenstein (bib8) 1996; 380
Fong, Rossant, Gertsenstein, Breitman (bib11) 1995; 376
Khaliq, Li, Shams, Sisi, Acevedo, Whittle (bib17) 1996; 13
Levine, Maynard, Qian, Lim, England, Yu (bib39) 2004; 350
Andraweera, Dekker, Thompson, North, McCowan, Roberts (bib25) 2011; 9
Bastek, Brown, Anton, Srinivas, D'Addio, Elovitz (bib41) 2010
Semenza (bib42) 2002; 64
Andraweera, Dekker, Thompson, North, McCowan, Roberts (bib26) 2011
Ferrara, Gerber, LeCouter (bib32) 2003; 9
Charnock-Jones, Kaufmann, Mayhew (bib7) 2004; 25
Ranheim, Staff, Henriksen (bib22) 2001; 80
Harris (bib36) 2011; 32
Andraweera PH, Dekke GA, Thompson SD, Roberts CT. Single nucleotide polymorphisms in the KDR gene in pregnancies complicated by gestational hypertensive disorders and small for gestational age infants. Reprod Sci. 2011;In Press.
Jarvenpaa, Vuoristo, Savolainen, Ukkola, Vaskivuo, Ryynanen (bib20) 2007; 23
Vuorela, Hatva, Lymboussaki, Kaipainen, Joukov, Persico (bib18) 1997; 56
Hutcheon, Lisonkova, Joseph (bib1) 2011
McCowan, Stewart, Francis, Gardosi (bib27) 2004; 44
Lash, Schiessl, Kirkley, Innes, Cooper, Searle (bib37) 2006; 80
Hanna, Goldman-Wohl, Hamani, Avraham, Greenfield, Natanson-Yaron (bib38) 2006; 12
Shalaby, Rossant, Yamaguchi, Gertsenstein, Wu, Breitman (bib12) 1995; 376
Jackson, Carney, Lye, Ritchie (bib14) 1994; 15
Lyall, Young, Boswell, Kingdom, Greer (bib35) 1997; 18
Andraweera, Dekker, Thompson, Nowak, Zhang, McCowan (bib43) 2011; 165
Clark, Smith, Sharkey, Charnock-Jones (bib13) 1996; 11
Carmeliet (10.1016/j.placenta.2012.02.013_bib9) 2001; 7
Sgambati (10.1016/j.placenta.2012.02.013_bib23) 2004; 111
Khong (10.1016/j.placenta.2012.02.013_bib3) 1986; 93
McCowan (10.1016/j.placenta.2012.02.013_bib24) 2009; 338
Mayhew (10.1016/j.placenta.2012.02.013_bib4) 2004; 25
Charnock-Jones (10.1016/j.placenta.2012.02.013_bib7) 2004; 25
Bastek (10.1016/j.placenta.2012.02.013_bib41) 2010
Kim (10.1016/j.placenta.2012.02.013_bib5) 2003; 189
Ferrara (10.1016/j.placenta.2012.02.013_bib10) 1996; 380
Schiessl (10.1016/j.placenta.2012.02.013_bib15) 2008
Chung (10.1016/j.placenta.2012.02.013_bib21) 2004; 89
Harris (10.1016/j.placenta.2012.02.013_bib36) 2011; 32
Sharkey (10.1016/j.placenta.2012.02.013_bib16) 1993; 99
Kim (10.1016/j.placenta.2012.02.013_bib6) 2002; 187
Clark (10.1016/j.placenta.2012.02.013_bib13) 1996; 11
Andraweera (10.1016/j.placenta.2012.02.013_bib26) 2011
Levine (10.1016/j.placenta.2012.02.013_bib39) 2004; 350
Marini (10.1016/j.placenta.2012.02.013_bib40) 2007; 19
Bodnar (10.1016/j.placenta.2012.02.013_bib2) 2008; 22
Hutcheon (10.1016/j.placenta.2012.02.013_bib1) 2011
Andraweera (10.1016/j.placenta.2012.02.013_bib25) 2011; 9
Ranheim (10.1016/j.placenta.2012.02.013_bib22) 2001; 80
10.1016/j.placenta.2012.02.013_bib44
Nelson (10.1016/j.placenta.2012.02.013_bib29) 2011; 32
Ahmed (10.1016/j.placenta.2012.02.013_bib31) 1995; 12
Lyall (10.1016/j.placenta.2012.02.013_bib35) 1997; 18
Larionov (10.1016/j.placenta.2012.02.013_bib28) 2005; 6
Lash (10.1016/j.placenta.2012.02.013_bib37) 2006; 80
Hanna (10.1016/j.placenta.2012.02.013_bib38) 2006; 12
Jackson (10.1016/j.placenta.2012.02.013_bib14) 1994; 15
Carmeliet (10.1016/j.placenta.2012.02.013_bib8) 1996; 380
Vuorela (10.1016/j.placenta.2012.02.013_bib18) 1997; 56
Demir (10.1016/j.placenta.2012.02.013_bib34) 2004; 25
Ferrara (10.1016/j.placenta.2012.02.013_bib32) 2003; 9
Demir (10.1016/j.placenta.2012.02.013_bib33) 2006; 27
Semenza (10.1016/j.placenta.2012.02.013_bib42) 2002; 64
Fong (10.1016/j.placenta.2012.02.013_bib11) 1995; 376
Clark (10.1016/j.placenta.2012.02.013_bib30) 1998; 159
McCowan (10.1016/j.placenta.2012.02.013_bib27) 2004; 44
Khaliq (10.1016/j.placenta.2012.02.013_bib17) 1996; 13
Cooper (10.1016/j.placenta.2012.02.013_bib19) 1996; 103
Jarvenpaa (10.1016/j.placenta.2012.02.013_bib20) 2007; 23
Andraweera (10.1016/j.placenta.2012.02.013_bib43) 2011; 165
Shalaby (10.1016/j.placenta.2012.02.013_bib12) 1995; 376
References_xml – volume: 32
  start-page: 195
  year: 2011
  end-page: 196
  ident: bib29
  article-title: A technical note to improve the reporting of studies of the human placenta
  publication-title: Placenta
– year: 2011
  ident: bib26
  article-title: A functional variant in ANGPT1 and the risk of pregnancies with hypertensive disorders and small for gestational age infants
  publication-title: Mol Hum Reprod
– volume: 99
  start-page: 609
  year: 1993
  end-page: 615
  ident: bib16
  article-title: Expression of mRNA for vascular endothelial growth factor in human placenta
  publication-title: J Reprod Fertil
– volume: 32
  start-page: S154
  year: 2011
  end-page: S158
  ident: bib36
  article-title: IFPA Gabor Than Award lecture: transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline
  publication-title: Placenta
– year: 2008
  ident: bib15
  article-title: Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy
  publication-title: Placenta
– volume: 338
  start-page: b1081
  year: 2009
  ident: bib24
  article-title: Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study
  publication-title: BMJ
– volume: 9
  start-page: 669
  year: 2003
  end-page: 676
  ident: bib32
  article-title: The biology of VEGF and its receptors
  publication-title: Nat Med
– volume: 165
  start-page: 1123
  year: 2011
  end-page: 1130
  ident: bib43
  article-title: Association of vascular endothelial growth factor +936 C/T single-nucleotide polymorphism with pregnancies complicated by small-for-gestational-age babies
  publication-title: Arch Pediatr Adolesc Med
– volume: 376
  start-page: 66
  year: 1995
  end-page: 70
  ident: bib11
  article-title: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
  publication-title: Nature
– volume: 12
  start-page: 1065
  year: 2006
  end-page: 1074
  ident: bib38
  article-title: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
  publication-title: Nat Med
– volume: 23
  start-page: 351
  year: 2007
  end-page: 355
  ident: bib20
  article-title: Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction
  publication-title: Gynecol Endocrinol
– volume: 12
  start-page: 235
  year: 1995
  end-page: 243
  ident: bib31
  article-title: Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta
  publication-title: Growth Factor
– volume: 25
  start-page: 127
  year: 2004
  end-page: 139
  ident: bib4
  article-title: Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies
  publication-title: Placenta
– volume: 380
  start-page: 439
  year: 1996
  end-page: 442
  ident: bib10
  article-title: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
  publication-title: Nature
– year: 2011
  ident: bib1
  article-title: Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy
  publication-title: Best Pract Res Clin Obstet Gynaecol
– volume: 25
  start-page: 103
  year: 2004
  end-page: 113
  ident: bib7
  article-title: Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation
  publication-title: Placenta
– volume: 15
  start-page: 341
  year: 1994
  end-page: 353
  ident: bib14
  article-title: Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation
  publication-title: Placenta
– volume: 111
  start-page: 564
  year: 2004
  end-page: 570
  ident: bib23
  article-title: VEGF expression in the placenta from pregnancies complicated by hypertensive disorders
  publication-title: BJOG
– volume: 18
  start-page: 269
  year: 1997
  end-page: 276
  ident: bib35
  article-title: Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery
  publication-title: Placenta
– volume: 19
  start-page: 641
  year: 2007
  end-page: 651
  ident: bib40
  article-title: Expression of vascular endothelial growth factor receptor types 1, 2 and 3 in placenta from pregnancies complicated by hypertensive disorders
  publication-title: Reprod Fertil Dev
– volume: 64
  start-page: 993
  year: 2002
  end-page: 998
  ident: bib42
  article-title: Signal transduction to hypoxia-inducible factor 1
  publication-title: Biochem Pharmacol
– volume: 27
  start-page: 535
  year: 2006
  end-page: 539
  ident: bib33
  article-title: Sequential steps during vasculogenesis and angiogenesis in the very early human placenta
  publication-title: Placenta
– year: 2010
  ident: bib41
  article-title: Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth
  publication-title: J Matern Fetal Neonatal Med
– volume: 22
  start-page: 538
  year: 2008
  end-page: 545
  ident: bib2
  article-title: The prevalence of preterm birth and season of conception
  publication-title: Paediatr Perinat Epidemiol
– volume: 11
  start-page: 1090
  year: 1996
  end-page: 1098
  ident: bib13
  article-title: Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy
  publication-title: Hum Reprod
– volume: 187
  start-page: 1137
  year: 2002
  end-page: 1142
  ident: bib6
  article-title: Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes
  publication-title: Am J Obstet Gynecol
– volume: 80
  start-page: 93
  year: 2001
  end-page: 98
  ident: bib22
  article-title: VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery
  publication-title: Acta Obstet Gynecol Scand
– volume: 376
  start-page: 62
  year: 1995
  end-page: 66
  ident: bib12
  article-title: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
  publication-title: Nature
– volume: 25
  start-page: 560
  year: 2004
  end-page: 572
  ident: bib34
  article-title: Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis
  publication-title: Placenta
– reference: Andraweera PH, Dekke GA, Thompson SD, Roberts CT. Single nucleotide polymorphisms in the KDR gene in pregnancies complicated by gestational hypertensive disorders and small for gestational age infants. Reprod Sci. 2011;In Press.
– volume: 103
  start-page: 1191
  year: 1996
  end-page: 1196
  ident: bib19
  article-title: VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
  publication-title: Br J Obstet Gynaecol
– volume: 380
  start-page: 435
  year: 1996
  end-page: 439
  ident: bib8
  article-title: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
  publication-title: Nature
– volume: 9
  start-page: 2221
  year: 2011
  end-page: 2228
  ident: bib25
  article-title: A functional variant in the thrombospondin-1 gene and the risk of small for gestational age infants
  publication-title: J Thromb Haemost
– volume: 189
  start-page: 1063
  year: 2003
  end-page: 1069
  ident: bib5
  article-title: Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes
  publication-title: Am J Obstet Gynecol
– volume: 7
  start-page: 575
  year: 2001
  end-page: 583
  ident: bib9
  article-title: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
  publication-title: Nat Med
– volume: 44
  start-page: 428
  year: 2004
  end-page: 431
  ident: bib27
  article-title: A customised birthweight centile calculator developed for a New Zealand population
  publication-title: Aust N Z J Obstet Gynaecol
– volume: 6
  start-page: 62
  year: 2005
  ident: bib28
  article-title: A standard curve based method for relative real time PCR data processing
  publication-title: BMC Bioinform
– volume: 89
  start-page: 2484
  year: 2004
  end-page: 2490
  ident: bib21
  article-title: Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies
  publication-title: J Clin Endocrinol Metab
– volume: 93
  start-page: 1049
  year: 1986
  end-page: 1059
  ident: bib3
  article-title: Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants
  publication-title: Br J Obstet Gynaecol
– volume: 56
  start-page: 489
  year: 1997
  end-page: 494
  ident: bib18
  article-title: Expression of vascular endothelial growth factor and placenta growth factor in human placenta
  publication-title: Biol Reprod
– volume: 13
  start-page: 243
  year: 1996
  end-page: 250
  ident: bib17
  article-title: Localisation of placenta growth factor (PIGF) in human term placenta
  publication-title: Growth Factor
– volume: 159
  start-page: 459
  year: 1998
  end-page: 467
  ident: bib30
  article-title: Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
  publication-title: J Endocrinol
– volume: 80
  start-page: 572
  year: 2006
  end-page: 580
  ident: bib37
  article-title: Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy
  publication-title: J Leukoc Biol
– volume: 350
  start-page: 672
  year: 2004
  end-page: 683
  ident: bib39
  article-title: Circulating angiogenic factors and the risk of preeclampsia
  publication-title: N Engl J Med
– volume: 18
  start-page: 269
  issue: 4
  year: 1997
  ident: 10.1016/j.placenta.2012.02.013_bib35
  article-title: Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery
  publication-title: Placenta
  doi: 10.1016/S0143-4004(97)80061-6
– volume: 12
  start-page: 1065
  issue: 9
  year: 2006
  ident: 10.1016/j.placenta.2012.02.013_bib38
  article-title: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
  publication-title: Nat Med
  doi: 10.1038/nm1452
– volume: 376
  start-page: 66
  issue: 6535
  year: 1995
  ident: 10.1016/j.placenta.2012.02.013_bib11
  article-title: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
  publication-title: Nature
  doi: 10.1038/376066a0
– volume: 99
  start-page: 609
  issue: 2
  year: 1993
  ident: 10.1016/j.placenta.2012.02.013_bib16
  article-title: Expression of mRNA for vascular endothelial growth factor in human placenta
  publication-title: J Reprod Fertil
  doi: 10.1530/jrf.0.0990609
– volume: 189
  start-page: 1063
  issue: 4
  year: 2003
  ident: 10.1016/j.placenta.2012.02.013_bib5
  article-title: Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes
  publication-title: Am J Obstet Gynecol
  doi: 10.1067/S0002-9378(03)00838-X
– volume: 25
  start-page: 127
  issue: 2–3
  year: 2004
  ident: 10.1016/j.placenta.2012.02.013_bib4
  article-title: Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies
  publication-title: Placenta
  doi: 10.1016/j.placenta.2003.10.010
– volume: 6
  start-page: 62
  year: 2005
  ident: 10.1016/j.placenta.2012.02.013_bib28
  article-title: A standard curve based method for relative real time PCR data processing
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-6-62
– volume: 376
  start-page: 62
  issue: 6535
  year: 1995
  ident: 10.1016/j.placenta.2012.02.013_bib12
  article-title: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
  publication-title: Nature
  doi: 10.1038/376062a0
– volume: 9
  start-page: 2221
  issue: 11
  year: 2011
  ident: 10.1016/j.placenta.2012.02.013_bib25
  article-title: A functional variant in the thrombospondin-1 gene and the risk of small for gestational age infants
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2011.04494.x
– volume: 80
  start-page: 572
  issue: 3
  year: 2006
  ident: 10.1016/j.placenta.2012.02.013_bib37
  article-title: Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0406250
– volume: 159
  start-page: 459
  issue: 3
  year: 1998
  ident: 10.1016/j.placenta.2012.02.013_bib30
  article-title: Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
  publication-title: J Endocrinol
  doi: 10.1677/joe.0.1590459
– volume: 19
  start-page: 641
  issue: 5
  year: 2007
  ident: 10.1016/j.placenta.2012.02.013_bib40
  article-title: Expression of vascular endothelial growth factor receptor types 1, 2 and 3 in placenta from pregnancies complicated by hypertensive disorders
  publication-title: Reprod Fertil Dev
  doi: 10.1071/RD06131
– year: 2010
  ident: 10.1016/j.placenta.2012.02.013_bib41
  article-title: Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth
  publication-title: J Matern Fetal Neonatal Med
– volume: 56
  start-page: 489
  issue: 2
  year: 1997
  ident: 10.1016/j.placenta.2012.02.013_bib18
  article-title: Expression of vascular endothelial growth factor and placenta growth factor in human placenta
  publication-title: Biol Reprod
  doi: 10.1095/biolreprod56.2.489
– volume: 9
  start-page: 669
  issue: 6
  year: 2003
  ident: 10.1016/j.placenta.2012.02.013_bib32
  article-title: The biology of VEGF and its receptors
  publication-title: Nat Med
  doi: 10.1038/nm0603-669
– volume: 111
  start-page: 564
  issue: 6
  year: 2004
  ident: 10.1016/j.placenta.2012.02.013_bib23
  article-title: VEGF expression in the placenta from pregnancies complicated by hypertensive disorders
  publication-title: BJOG
  doi: 10.1111/j.1471-0528.2004.00143.x
– volume: 22
  start-page: 538
  issue: 6
  year: 2008
  ident: 10.1016/j.placenta.2012.02.013_bib2
  article-title: The prevalence of preterm birth and season of conception
  publication-title: Paediatr Perinat Epidemiol
  doi: 10.1111/j.1365-3016.2008.00971.x
– volume: 93
  start-page: 1049
  issue: 10
  year: 1986
  ident: 10.1016/j.placenta.2012.02.013_bib3
  article-title: Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants
  publication-title: Br J Obstet Gynaecol
  doi: 10.1111/j.1471-0528.1986.tb07830.x
– volume: 165
  start-page: 1123
  issue: 12
  year: 2011
  ident: 10.1016/j.placenta.2012.02.013_bib43
  article-title: Association of vascular endothelial growth factor +936 C/T single-nucleotide polymorphism with pregnancies complicated by small-for-gestational-age babies
  publication-title: Arch Pediatr Adolesc Med
  doi: 10.1001/archpediatrics.2011.796
– volume: 11
  start-page: 1090
  issue: 5
  year: 1996
  ident: 10.1016/j.placenta.2012.02.013_bib13
  article-title: Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy
  publication-title: Hum Reprod
  doi: 10.1093/oxfordjournals.humrep.a019303
– volume: 44
  start-page: 428
  issue: 5
  year: 2004
  ident: 10.1016/j.placenta.2012.02.013_bib27
  article-title: A customised birthweight centile calculator developed for a New Zealand population
  publication-title: Aust N Z J Obstet Gynaecol
  doi: 10.1111/j.1479-828X.2004.00272.x
– volume: 12
  start-page: 235
  issue: 3
  year: 1995
  ident: 10.1016/j.placenta.2012.02.013_bib31
  article-title: Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta
  publication-title: Growth Factor
  doi: 10.3109/08977199509036883
– ident: 10.1016/j.placenta.2012.02.013_bib44
  doi: 10.1177/1933719111428520
– year: 2008
  ident: 10.1016/j.placenta.2012.02.013_bib15
  article-title: Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy
  publication-title: Placenta
– volume: 27
  start-page: 535
  issue: 6–7
  year: 2006
  ident: 10.1016/j.placenta.2012.02.013_bib33
  article-title: Sequential steps during vasculogenesis and angiogenesis in the very early human placenta
  publication-title: Placenta
  doi: 10.1016/j.placenta.2005.05.011
– year: 2011
  ident: 10.1016/j.placenta.2012.02.013_bib1
  article-title: Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy
  publication-title: Best Pract Res Clin Obstet Gynaecol
  doi: 10.1016/j.bpobgyn.2011.01.006
– volume: 25
  start-page: 103
  issue: 2–3
  year: 2004
  ident: 10.1016/j.placenta.2012.02.013_bib7
  article-title: Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation
  publication-title: Placenta
  doi: 10.1016/j.placenta.2003.10.004
– volume: 80
  start-page: 93
  issue: 2
  year: 2001
  ident: 10.1016/j.placenta.2012.02.013_bib22
  article-title: VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery
  publication-title: Acta Obstet Gynecol Scand
  doi: 10.1034/j.1600-0412.2001.080002093.x
– volume: 7
  start-page: 575
  issue: 5
  year: 2001
  ident: 10.1016/j.placenta.2012.02.013_bib9
  article-title: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
  publication-title: Nat Med
  doi: 10.1038/87904
– volume: 187
  start-page: 1137
  issue: 5
  year: 2002
  ident: 10.1016/j.placenta.2012.02.013_bib6
  article-title: Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes
  publication-title: Am J Obstet Gynecol
  doi: 10.1067/mob.2002.127720
– year: 2011
  ident: 10.1016/j.placenta.2012.02.013_bib26
  article-title: A functional variant in ANGPT1 and the risk of pregnancies with hypertensive disorders and small for gestational age infants
  publication-title: Mol Hum Reprod
– volume: 103
  start-page: 1191
  issue: 12
  year: 1996
  ident: 10.1016/j.placenta.2012.02.013_bib19
  article-title: VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
  publication-title: Br J Obstet Gynaecol
  doi: 10.1111/j.1471-0528.1996.tb09627.x
– volume: 32
  start-page: 195
  issue: 2
  year: 2011
  ident: 10.1016/j.placenta.2012.02.013_bib29
  article-title: A technical note to improve the reporting of studies of the human placenta
  publication-title: Placenta
  doi: 10.1016/j.placenta.2010.12.008
– volume: 350
  start-page: 672
  issue: 7
  year: 2004
  ident: 10.1016/j.placenta.2012.02.013_bib39
  article-title: Circulating angiogenic factors and the risk of preeclampsia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa031884
– volume: 338
  start-page: b1081
  year: 2009
  ident: 10.1016/j.placenta.2012.02.013_bib24
  article-title: Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study
  publication-title: BMJ
  doi: 10.1136/bmj.b1081
– volume: 64
  start-page: 993
  issue: 5–6
  year: 2002
  ident: 10.1016/j.placenta.2012.02.013_bib42
  article-title: Signal transduction to hypoxia-inducible factor 1
  publication-title: Biochem Pharmacol
  doi: 10.1016/S0006-2952(02)01168-1
– volume: 15
  start-page: 341
  issue: 4
  year: 1994
  ident: 10.1016/j.placenta.2012.02.013_bib14
  article-title: Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation
  publication-title: Placenta
  doi: 10.1016/0143-4004(94)90002-7
– volume: 89
  start-page: 2484
  issue: 5
  year: 2004
  ident: 10.1016/j.placenta.2012.02.013_bib21
  article-title: Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031580
– volume: 25
  start-page: 560
  issue: 6
  year: 2004
  ident: 10.1016/j.placenta.2012.02.013_bib34
  article-title: Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis
  publication-title: Placenta
  doi: 10.1016/j.placenta.2003.11.011
– volume: 380
  start-page: 435
  issue: 6573
  year: 1996
  ident: 10.1016/j.placenta.2012.02.013_bib8
  article-title: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
  publication-title: Nature
  doi: 10.1038/380435a0
– volume: 13
  start-page: 243
  issue: 3–4
  year: 1996
  ident: 10.1016/j.placenta.2012.02.013_bib17
  article-title: Localisation of placenta growth factor (PIGF) in human term placenta
  publication-title: Growth Factor
  doi: 10.3109/08977199609003225
– volume: 380
  start-page: 439
  issue: 6573
  year: 1996
  ident: 10.1016/j.placenta.2012.02.013_bib10
  article-title: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
  publication-title: Nature
  doi: 10.1038/380439a0
– volume: 23
  start-page: 351
  issue: 6
  year: 2007
  ident: 10.1016/j.placenta.2012.02.013_bib20
  article-title: Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction
  publication-title: Gynecol Endocrinol
  doi: 10.1080/09513590701350291
– volume: 32
  start-page: S154
  issue: Suppl. 2
  year: 2011
  ident: 10.1016/j.placenta.2012.02.013_bib36
  article-title: IFPA Gabor Than Award lecture: transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline
  publication-title: Placenta
  doi: 10.1016/j.placenta.2010.11.018
SSID ssj0009412
Score 2.3177085
Snippet The pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect approximately 21%...
AbstractIntroductionThe pregnancy complications preeclampsia, gestational hypertension, small for gestational age infants (SGA) and pre-term birth (PTB) affect...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 467
SubjectTerms Adult
Biological and medical sciences
Case-Control Studies
Embryology: invertebrates and vertebrates. Teratology
Female
Fundamental and applied biological sciences. Psychology
Humans
Hypertension, Pregnancy-Induced - metabolism
Infant, Newborn
Infant, Small for Gestational Age
Internal Medicine
mRNA
Obstetrics and Gynecology
Placenta
Placenta - metabolism
Placenta - pathology
Placenta Growth Factor
Pre-Eclampsia - metabolism
Pre-term birth
Preeclampsia
Pregnancy
Pregnancy Outcome
Pregnancy Proteins - genetics
Premature Birth - metabolism
RNA, Messenger - metabolism
SGA
Vascular Endothelial Growth Factor A - biosynthesis
Vascular Endothelial Growth Factor A - genetics
Vascular Endothelial Growth Factor A - metabolism
Vascular Endothelial Growth Factor Receptor-1 - genetics
Vascular Endothelial Growth Factor Receptor-2 - genetics
VEGF family
Title Placental expression of VEGF family mRNA in adverse pregnancy outcomes
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0143400412001002
https://www.clinicalkey.es/playcontent/1-s2.0-S0143400412001002
https://dx.doi.org/10.1016/j.placenta.2012.02.013
https://www.ncbi.nlm.nih.gov/pubmed/22386962
https://www.proquest.com/docview/1011538371
Volume 33
WOSCitedRecordID wos000304518200003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1532-3102
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009412
  issn: 0143-4004
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ti9NAEF68OxVBRO98qS9lBfHL0TNNNtnsx6LtqWgpckrxS9hNNnLVJqVJtffvnX1LWrR4CkIJZdPdJJ1nZ2cnz8wg9CwGIzjLUtELFIWGqIKpzPdEj3sSVqM8jLjQ2fXf0fE4nk7ZxNLGKl1OgBZFvF6zxX8VNbSBsFXo7F-IuxkUGuA7CB2OIHY4XkrwE-UY1zGOcm1Zrtok_DQ8HTl_xvzDeKA8HVyVY65UrJT8ojJvXByXqxpuyhILZ9sjKmt0yKvaOUI3fAjZkv-QUtcsOp60AQ-v5FfL2jhtnaYqFFvpEw2gttlwvE3GA0vdtt4IRetwrKkT6TSoyoLobalYk-vCQmlTXxJTi-MXPW5cCrOThX1AxcHzdXJVE7m6IcfFXAsSzJw4Ylazb2fQdqf20IFPQwa672DwZjh92yZnJn1_I3r895dVaaPtQLtsmJsLXsHMyk1JlN17Fm27nN1Gt-ymAw8MWO6gK7I4REeDgtfl_AI_x5oGrN-vHKLr7y3b4hBd-1zqxiM0akCFW1DhMscKVNiACitQ4fMCW1DhBlTYgeou-jganr183bMVOHppSEndk2GewxY6hwnLs1AENAzTKAXlQz0BE1wEEvabkcgJAV3gy4xluU9SwpkXeUKA6r-H9ouykA8QJh7N-kKEKZWSkNTnMUtzEUk_IDFnYdZBoftPk9Smp1dVUr4ljoc4S5xYEiWWxINPP-igF02_hUnQ8sce1IksceHHsGAmgL1_6ykrO_2rpJ9U8EtNmQyIzmWnnC6e30Gs6WlNW2OyXuqq3S1cNY_ph2DKMEo66KkDWgKLg3rjxwtZrio1qrJoAtrvoPsGgW1vC-aHO888QjfaKf4Y7dfLlXyCrqbf6_Nq2UV7dBp37VT6CdrJ3aQ
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Placental+expression+of+VEGF+family+mRNA+in+adverse+pregnancy+outcomes&rft.jtitle=Placenta+%28Eastbourne%29&rft.au=Andraweera%2C+P+H&rft.au=Dekker%2C+G+A&rft.au=Laurence%2C+J+A&rft.au=Roberts%2C+C+T&rft.date=2012-06-01&rft.eissn=1532-3102&rft.volume=33&rft.issue=6&rft.spage=467&rft_id=info:doi/10.1016%2Fj.placenta.2012.02.013&rft_id=info%3Apmid%2F22386962&rft.externalDocID=22386962
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01434004%2FS0143400412X00067%2Fcov150h.gif